Independent Medical Education Request for Proposals: Improving Shared Decision Making in Hemophilia – Visiting Professorship Program
Funding for organizations to host Visiting Professors who provide education on shared decision making and emerging therapies in hemophilia care.
Funder: Pfizer Inc.
Due Dates: June 18, 2026 (Full application submission deadline, 5:00 PM ET)
Funding Amounts: Up to $6,000 per award for local program costs; Visiting Professor travel/honoraria covered separately; ~12 sites funded
Summary: Supports organizations to host Visiting Professorships focused on shared decision making and new therapies in hemophilia care.
Description
This grant, jointly offered by Pfizer and the Hemostasis & Thrombosis Research Society (HTRS), supports organizations in hosting a Visiting Professorship program aimed at improving education around shared decision making (SDM) and emerging therapeutic options in hemophilia care. The program is designed to address specific educational gaps identified by the applicant institution, with up to two days of tailored educational activities led by a distinguished Visiting Professor (or Professors) selected by HTRS. The initiative targets academic clinicians, physician-scientists, multidisciplinary care teams, and patient advocacy groups, aiming to foster enduring improvements in patient care and clinician knowledge.
